(Allergan plc)

	AGN latest price $254.5427 (-0.69%) ($250.7496 - $254.6874) on Tue. Dec. 9, 2014.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.96% (three month average)
RSI	43
Latest Price	$254.5427(-0.69%)
Stocks Behave Similarly	Similar Stock List
Weekly Trend	AGN advances 0.3% a week on average for past two weeks.
Market Behavior	Value stocks sell-off for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(55%)    IBB(54%)    XBI(47%)    SPY(43%)    IVE(42%)
Factors Impacting AGN price	AGN will decline at least -0.98% in a week (0% probabilities).   VIXM(-32%)    TLT(-18%)    SHY(-7%)    UUP(-5%)    IGOV(-5%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.98% (StdDev 1.96%)
Hourly BBV	0 ()
Intraday Trend	1.1%

5 Day Moving Average	$256.48(-0.76%)
10 Day Moving Average	$257.34(-1.09%)
20 Day Moving Average	$251.67(1.14%)
To recent high	-2.5%
To recent low	21.4%
Market Cap	$83.923b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed